Ia. PERSONALIZED MEDICINE PROMISES TO ADVANCE HEALTH CARE

The sequencing of the human genome has opened the door for physicians and pharmaceutical companies to design highly customized treatments that are as unique as each individual patient. Our panel of scientific and policy experts will discuss the impact of Personalized Medicine on: (i) The drug discovery and approval processes. (Is this the end of the blockbuster?); (ii) Integration of diagnostics into drug regimens. (Is there an Amplichip in your doctor’s office?); and (iii) The ethics and confidentiality issues of genotypically isolating patient groups. (Are you at risk for heart disease? Who should know?)